Medical Devices North America

North America Heart Failure Devices Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

North America Heart Failure Devices Market Industry Trends and Forecast to 2034: Segmented by (Device, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

North America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $5.49 Bn Placeholder estimate
Estimate 2025 $5.89 Bn 45.9% of the global market
Projected 2034 $11.10 Bn 88.5% Adds $5.21 Bn over 9 forecast years
CAGR 2025–2034 7.3% Faster than 45% of 173 Medical Devices markets here
Key players 5
  • North America is 45.9% of the global market.
  • Among regions, the largest is North America (this report) at $5.89 Bn.
  • Fastest growing: Latin America at 9.3% a year.
  • North America ranks 1st of 6 by size among regions.

Market size projection

North America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$5.21 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Heart Failure Devices Market market size by year, North America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $5.49 Bn — —
2025 (base) $5.89 Bn +$400.6 Mn —
2026 (forecast) $6.32 Bn +$429.9 Mn +7.3%
2027 (forecast) $6.78 Bn +$461.3 Mn +15.1%
2028 (forecast) $7.27 Bn +$494.9 Mn +23.5%
2029 (forecast) $7.81 Bn +$531.1 Mn +32.6%
2030 (forecast) $8.38 Bn +$569.8 Mn +42.2%
2031 (forecast) $8.99 Bn +$611.4 Mn +52.6%
2032 (forecast) $9.64 Bn +$656.1 Mn +63.8%
2033 (forecast) $10.35 Bn +$703.9 Mn +75.7%
2034 (forecast) $11.10 Bn +$755.3 Mn +88.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

North America Heart Failure Devices Market Analysis at a glance
Market size, 2025$5.89 Bn placeholder estimate
Forecast, 2034$11.10 Bn placeholder estimate
Growth (CAGR), 2025–20347.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDevice, use and end user (see all)
Key playersAbbott Laboratories, Medtronic, Boston Scientific Corporation, Abiomed (Johnson & Johnson), Impulse Dynamics (see all)
Active clinical trials34 in North AmericaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The North America Heart Failure Devices Market Analysis Executive Summary

Heart failure devices help weak hearts pump or keep rhythm, including pumps, defibrillators, resynchronisation devices and sensors.

Key segments of the heart Failure Devices market include device (Ventricular Assist Devices, CRT Devices and ICDs) and use (Bridge to Transplant, Destination Therapy and Monitoring).

Bar chart: North America Heart Failure Devices market size, 2024–2034, placeholder estimates. $5.49 Bn in 2024, $5.89 Bn in 2025 and $11.10 Bn in 2034, 7.3% CAGR.
North America Heart Failure Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

North America Heart Failure Devices Market Dynamics

Market Growth Drivers

Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the heart Failure Devices market.

Opportunity

Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the heart Failure Devices market room to grow.

Market Restraints

High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the heart Failure Devices market.

Competitive Landscape for Heart Failure Devices Market in North America

The heart Failure Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Heart Failure Devices Market in North America

Heart Failure Devices in North America: rules, payment and research

In the countries we cover here, medical devices are regulated by Health Canada (Canada)⁠[1] and FDA (US)⁠[2]. How care is paid for in these countries: provincial health insurance (Canada)⁠[3] and Medicare and Medicaid (US)⁠[4]. ClinicalTrials.gov lists 34 studies on Heart Failure Devices that are recruiting, active or about to start in North America.⁠[5]

[1] Health Canada. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] Health Canada. Checked 14 Nov 2026.

[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how heart Failure Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in North America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Heart Failure Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Heart Failure Devices in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Heart Failure Devices market in North America?
Placeholder estimate: about $5.89 Bn in 2025, rising to about $11.10 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Heart Failure Devices market in North America growing?
Placeholder estimate: about 7.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Heart Failure Devices market report cover?
The report splits the market by device (Ventricular Assist Devices, CRT Devices, ICDs, Implantable Monitors), use (Bridge to Transplant, Destination Therapy, Monitoring) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Heart Failure Devices market?
Key players include Abbott Laboratories, Medtronic, Boston Scientific Corporation, Abiomed (Johnson & Johnson) and Impulse Dynamics.
What is driving the Heart Failure Devices market?
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the heart Failure Devices market.
How many clinical trials on Heart Failure Devices are running in North America?
34 studies are recruiting, active or about to start in North America, counted across the 2 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
How much research is published on Heart Failure Devices?
PubMed lists 11,276 papers on Heart Failure Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in North America

See all

Related on cardiovascular

See the topic